Clonazepam

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Biochem/physiol Actions Anticonvulsant ligand for the GABA A receptor benzodiazepine modulatory site. Features and Benefits This compound was developed by Roche .

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Clonazepam, marketed under trade names such as Klonopin and Rivotril, is a potent, long-acting benzodiazepine with anxiolytic, anticonvulsant, muscle relaxant and hypnotic properties. Clonazepam is prescribed for the treatment of epilepsy.

Clonazepam, sold under trade names Klonopin &#174 or Rivotril, is a long-acting, potent benzodiazepine approved for the treatment of epilepsy. This stable-labeled internal standard is suitable for use in LC/MS or GC/MS applications including

Clonazepam, sold under trade names Klonopin &#174 or Rivotril, is a long-acting, potent benzodiazepine approved for the treatment of epilepsy. This stable-labeled internal standard is suitable for use in LC/MS or GC/MS applications including